Clinical Cancer Research Review Committee
The scientific review, prioritization, and monitoring of all new and ongoing cancer-related clinical trials within Thomas Jefferson University (TJU), are the responsibility of the Clinical Cancer Research Review Committee (CCRRC). This review is required prior to submission to the TJU IRB.
Meeting Times and Submission Details
Please keep in mind that the CCRRC has decided to cancel the December 24th meeting this year. The next meeting is scheduled for January 14th, 2013.
The CCRRC has recently begun accepting new submissions by email only. Please email all of the required documents listed below to email@example.com. The CCRRC meets on the 2nd and 4th Monday of each month and materials need to the CCRRC by email by 9:00 AM on the Monday before the next CCRRC meeting.
Documents to be submitted to CCRRC:
- Multidisciplinary Working Group SOP
- Protocol Cover Sheet - electronic
Resource: The NCI Definitons Guide will aide you in the terminology used in the Protocol Cover Sheet.
- Clinical Trial Protocol - electronic
If you are submitting a protocol for an investigator initiated trial (IIT) please use the recommended format.
The CCRRC is chaired by Scott A. Waldman, M.D., PhD Chairman of the Division of Pharmacology and Experimental Therapeutics and coordinated by Sylvia Salazar, MD from the Clinical Research Management Office.